Clinical features and survival of patients with multiple primary malignancies

doi:10.12998/wjcc.v9.i34.10484

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 34

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2769)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

194

WORD

HTML

1218

Figures (1-3)

303

Tables (1-5)

177

Sum=1983

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

282

Download

504

Sum=786

Dec 6, 2021 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Cases. Dec 6, 2021; 9(34): 10484-10493
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10484

Table 1 The characteristics of patients with two malignancies, n (%)

Characteristics	Synchronous MPM	Metachronous MPM	Total
Patients	51 (23.0)	171 (77.0)	222 (100)
Gender
Male	32 (62.7)	87 (50.9)	119 (53.6)
Female	19 (37.3)	84 (49.1)	103 (46.4)
Age in yr, median (range)
First cancer	62 (32-84)	55 (19-87)	56 (19-87)
Second cancer	62 (32-84)	64 (28-90)	64 (28-90)
The most common sites in first primary cancers
1^st	Esophagus, 9 (17.6)	Breast, 31 (18.1)	Breast, 33 (14.9)
2^nd	Colorectum, 8 (15.7)	Colorectum, 23 (13.7)	Colorectum, 31 (14.0)
3^rd	Bladder/thyroid/hypopharynx, 4 (7.8), respectively	Stomach, 14 (8.2)	Stomach, 17 (7.7)
The most common sites in second primary cancers
1^st	NSCLC, 12 (23.5)	NSCLC, 54 (31.6)	NSCLC,66 (29.7)
2^nd	Stomach, 9 (17.6)	Stomach, 15 (8.8)	Stomach, 24 (10.8)
3^rd	Esophagus/kidney, 6 (11.8), respectively	Liver, 13 (7.6)	Esophagus/liver, 16 (7.2), respectively
Median interval (range) between the first and second cancers (mo)	0.2 (0-5.9)	73.2 (6.3-536.8)	43.6 (0-536.8)
Metastasis	16 (31.4)	83 (48.5)	99 (44.6)
Median overall survival in mo	36.4	35.3	35.4

MPM: Multiple primary malignancies; NSCLC: Non-small cell lung cancer.

Citation: Wang XK, Zhou MH. Clinical features and survival of patients with multiple primary malignancies. World J Clin Cases 2021; 9(34): 10484-10493
URL: https://www.wjgnet.com/2307-8960/full/v9/i34/10484.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i34.10484